© 2023 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Multiple myeloma
A Multiple Myeloma Cancer Diary
Three-Drug Therapy Plus Stem Cell Transplant Delays Progression
Multiple Myeloma 101

Now Approved Cancer Drugs — Spring 2023

Newly FDA-approved drugs for ovarian, bladder, liver cancer, and more.
Joshua Hill, MD, is a physician-scientist who works on antibody responses in blood cancer.

How Blood Cancer Research Might Help Organ Transplant Patients

Fred Hutch study suggests certain immune cells are the source of antibodies that attack donated organs.
3D rendering of white and red blood cells

What’s Next in Blood Cancer: Looking Ahead to 2023

Immunotherapy leads the way, along with promising breakthroughs for treating leukemia and multiple myeloma.
Myeloma cells (purple) in a patient's bone marrow, with a few normal cells in pink in the background.

New Approach Could Make Bone Marrow Transplants Safer, Stronger

Tests prevented relapse and limited graft-vs.-host disease (GVHD) in laboratory models of leukemia and multiple myeloma.

Tecvayli Shows Promise for People with Heavily Pretreated Multiple Myeloma

UPDATE: On October 25, the FDA approved Tecvayli (teclistamab) to treat some people with multiple myeloma.
Bryon Daily

Finding New Purpose After Multiple Meyloma

After treatment for multiple myeloma, Bryon Daily pays it forward to other African Americans, who are at higher risk for this cancer.

MUST read

Blood Cancers 101
An African American man wearing eyeglasses sits in a doctor's office
Multiple Myeloma Presents Added Burden for African Americans
vials of blood with red tops
New Studies Highlight How Immunotherapies Are Transforming Care for Blood Cancers

Cancer Survivors May Not Be at Greater Risk for COVID Complications

People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
T cells attack a cancer cell

FDA Approves Second CAR-T Therapy for Multiple Myeloma

98% of people who received the customized immunotherapy responded to the one-time treatment.

Real Health Focus

Multiple myeloma cells

Groups at High Risk for Multiple Myeloma Have Elevated Rates of Blood Cancer Precursor Condition

Screening high-risk groups could improve the survival of patients who develop myeloma.

New Studies Highlight How Immunotherapies Are Transforming Care for Blood Cancers

Researchers are examining opportunities for immune-modulating approaches to improve outcomes and reduce side effects.
Kellie Smith

A Multiple Myeloma Diary: Kellie Smith

Kellie Smith, 52, lives in Austin with her husband and child. She has multiple myeloma.
Colin Powell

Colin Powell Dies of COVID-19 at Age 84

Powell had received treatment for multiple myeloma, which can lead to poorer response to COVID-19 vaccines.

Multiple Myeloma Presents Added Burden for African Americans

African Americans are twice as likely to be diagnosed with multiple myeloma as white people, but lag in treatment gains.
Charlie Callagan at home in Merlin, Oregon

COVID-Overwhelmed Hospitals Postpone Cancer Care and Other Treatment

Hospitals are filling up with COVID-19 patients and other medical conditions are going untreated.

U.S. OK’s Third COVID-19 Vaccine Dose for Immunocompromised People

The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
Advertisement
Newsfeed
Real Health Stories

Real Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Real Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.